(Q36941918)

17 August 2017

1 reference

title

Multiple sclerosis symptom management (English)

1 reference

17 August 2017

1 reference

Adrienne R Boissy

1

1 reference

17 August 2017

Jeffrey A Cohen

series ordinal

2

1 reference

17 August 2017

publication date

1 September 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

9

1 reference

17 August 2017

page(s)

1213-1222

1 reference

Axonal transection in the lesions of multiple sclerosis

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Neurosurgical treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

The surgical treatment of spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Movement disorders in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

High resolution magnetic resonance imaging in peripheral vestibular dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Pontine lesions mimicking acute peripheral vestibulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Risks of falls in subjects with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Physical training and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Motor vehicle crashes and violations among drivers with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Factors associated with carer strain in carers of people with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Three screening batteries to detect cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Anxiety disorders and their clinical correlates in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Psychiatric disorder in a sample of the general population with and without chronic medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Cause of death in patients attending multiple sclerosis clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

An examination of suicidal intent in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Safety and adverse event profile of duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Reiterated intravesical instillation of capsaicin in neurogenic detrusor hyperreflexia: a 5-years experience of 100 instillations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Urinary, faecal and sexual dysfunction in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Fatigue and magnetic resonance imaging activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Sleep problems in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

A Systematic Review of Modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Multiple sclerosis: symptomatic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

21 January 2018

The neurobiology of pain

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.9.1213

10.1586/14737175.7.9.1213

21 January 2018

Identifiers

DOI

1 reference

release_7y2tlv7jkrandcxfevxh4z6fee

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7y2tlv7jkrandcxfevxh4z6fee

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference